We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+2.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$16.2B
AUM Growth
-$1.27B
(-7.2%)
Cap. Flow
-$1.42B
Cap. Flow
% of AUM
-8.75%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
1,414
New
206
Increased
348
Reduced
372
Closed
450
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$456M |
| 2 |
Intel
INTC
|
+$290M |
| 3 |
Union Pacific
UNP
|
+$159M |
| 4 |
AT&T
T
|
+$143M |
| 5 |
Philip Morris
PM
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$394M |
| 2 |
AstraZeneca
AZN
|
+$307M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
TSMC
TSM
|
+$187M |
| 5 |
Canadian National Railway
CNI
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.82% |
| 2 | Financials | 15.5% |
| 3 | Healthcare | 9.75% |
| 4 | Industrials | 8.83% |
| 5 | Consumer Discretionary | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Booz Allen Hamilton
BAH
$9.15B
| $6.97M | 0.04% |
240,924
+115,875
| +93% | +$3.37M |
|
352
Visa
V
$677B
| $6.94M | 0.04% |
+106,100
| New | +$7.02M |
|
353
CBRE Group
CBRE
$42.9B
| $6.91M | 0.04% |
+178,601
| New | +$6.16M |
|
354
TechnipFMC
FTI
$27.3B
| $6.85M | 0.04% |
+248,764
| New | +$7.29M |
|
355
Emergent Biosolutions
EBS
$248M
| $6.67M | 0.04% |
232,054
-23,031
| -9% | -$661K |
|
356
Restaurant Brands International
QSR
$25.8B
| $6.61M | 0.04% |
172,130
+27,356
| +19% | +$1.09M |
|
357
Avient
AVNT
$4.19B
| $6.51M | 0.04% |
174,415
+61,547
| +55% | +$2.34M |
|
|
HPP
358
Hudson Pacific Properties
HPP
$779M
| $6.5M | 0.04% |
27,982
+13,684
| +96% | +$3.07M |
|
359
CAE Inc. Common Shares
CAE
$8.74B
| $6.45M | 0.04% |
552,353
-175,914
| -24% | -$2.15M |
|
360
First Bancorp
FBP
$4.38B
| $6.44M | 0.04% |
1,039,080
+467,438
| +82% | +$2.84M |
|
|
HR
361
DELISTED
Healthcare Realty Trust Incorporated
HR
| $6.39M | 0.04% |
230,105
+4,725
| +2% | +$135K |
|
362
Teradyne
TER
$59.3B
| $6.36M | 0.04% |
337,318
-200,492
| -37% | -$3.84M |
|
363
Insight Enterprises
NSIT
$4.38B
| $6.33M | 0.04% |
222,073
+28,782
| +15% | +$741K |
|
|
AXIA
364
DELISTED
AXIA Energia
AXIA
| $6.33M | 0.04% |
4,414,187
-778,215
| -15% | -$1.16M |
|
365
Harmonic Inc
HLIT
$1.28B
| $6.28M | 0.04% |
847,103
+98,425
| +13% | +$731K |
|
|
ENIA
366
DELISTED
Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock)
ENIA
| $6.27M | 0.04% |
715,201
-2,527,701
| -78% | -$21.7M |
|
|
CMA
367
DELISTED
Comerica
CMA
| $6.24M | 0.04% |
138,290
-159,356
| -54% | -$7.11M |
|
368
IQVIA
IQV
$39.3B
| $6.22M | 0.04% |
92,893
-48,639
| -34% | -$3.07M |
|
|
XL
369
DELISTED
XL Group Ltd.
XL
| $6.13M | 0.04% |
166,722
+142,900
| +600% | +$5.12M |
|
|
DNR
370
DELISTED
Denbury Resources, Inc.
DNR
| $6.1M | 0.04% |
836,182
+386,221
| +86% | +$2.99M |
|
|
FCH
371
DELISTED
Felcor Lodging Trust
FCH
| $6.1M | 0.04% |
530,588
-54,198
| -9% | -$583K |
|
372
CEMIG Preferred Shares
CIG
$6.01B
| $6.07M | 0.04% |
2,909,511
+142,295
| +5% | +$311K |
|
373
Banco Bradesco
BBD
$36.7B
| $6.04M | 0.04% |
1,383,250
-6,105,027
| -82% | -$29.9M |
|
374
Capitol Federal Financial
CFFN
$1.1B
| $6.04M | 0.04% |
483,070
-229,360
| -32% | -$2.88M |
|
375
Vail Resorts
MTN
$5.3B
| $6.01M | 0.04% |
58,153
+46,228
| +388% | +$4.19M |
|
Similar funds
VGA
Arrowstreet Capital's Q1 2015 Portfolio in Review
As of Q1 2015, Arrowstreet Capital held 1,414 positions worth $16.2B, down 7.2% from $17.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Arrowstreet Capital withdrew a net $1.42B in Q1 2015, closing 450 positions and reducing 372 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $394M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Arrowstreet Capital opened a new position in Apple worth $470M.
- Arrowstreet Capital's largest Q1 2015 buy was Apple: 15,110,160 shares worth $470M.
- Arrowstreet Capital added most to Intel in Q1 2015, an estimated $290M increase.
- Arrowstreet Capital's biggest Q1 2015 reduction was AstraZeneca, cutting an estimated $307M.
- Arrowstreet Capital fully exited Teva Pharmaceuticals in Q1 2015, selling an estimated $394M.
- Arrowstreet Capital's ten largest holdings make up 18% of its $16.2B portfolio in Q1 2015.
- Arrowstreet Capital opened 206 new positions and closed 450 in Q1 2015.
- Arrowstreet Capital's portfolio value fell 7.2% quarter-over-quarter to $16.2B.
Based on Arrowstreet Capital's 13F filing for Q1 2015, filed 15 May 2015.